Discussion on the Treatment of Acute Exacerbation of Rheumatoid Arthritis-Associated Interstitial Lung Disease Based on ZHANG Jingyue's View of Yin-Yang Holism
LIANG Yanxia,LI Guangsen,WANG Wenwen,et al.Discussion on the Treatment of Acute Exacerbation of Rheumatoid Arthritis-Associated Interstitial Lung Disease Based on ZHANG Jingyue's View of Yin-Yang Holism[J].Journal of Traditional Chinese Medicine,2024,65(18):1943-1947.
LIANG Yanxia,LI Guangsen,WANG Wenwen,et al.Discussion on the Treatment of Acute Exacerbation of Rheumatoid Arthritis-Associated Interstitial Lung Disease Based on ZHANG Jingyue's View of Yin-Yang Holism[J].Journal of Traditional Chinese Medicine,2024,65(18):1943-1947.DOI: 10.13288/j.11-2166/r.2024.18.016.
This article is based on ZHANG Jingyue's theory of
yin
-
yang
holism to explore the etiology, pathogenesis, and treatment of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). It is believed that the foundation of acute exacerbation of RA-ILD lies in real
yin
insufficiency and
yin
fail to control
yang
; external pathogen attacking is a common cause of acute exacerbation of RA-ILD. For treatment, it is important to first suppress ministerial fire by prescribing modified
Yinhuo Decoction
(引火汤); if ministerial fire submerged, focus should be on nourishing both
yin
and
yang
; if real
yin
deficiency is the main issue, modified
Zuogui Pill
(左归丸) should be used; if real
yang
deficiency is prominent as well, modified
Yougui Pill
(右归丸) can be chosen. When
yin
and
yang
balanced, the disease could be solved.
关键词
Keywords
references
AKIYAMA M , KANEKO Y . Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease [J]. Autoimmun Rev , 2022 , 21 ( 5 ): 103056 .
KADURA S , RAGHU G . Rheumatoid arthritis-interstitial lung disease: manifestations and current concepts in pathogenesis and management [J]. Eur Respir Rev , 2021 , 30 ( 160 ): 210011 - 210028 .
LI L , LIU R , ZHANG Y , et al . A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease [J]. Clin Rheumatol , 2020 , 39 ( 5 ): 1457 - 1470 .
YOO H , HINO T , HWANG J , et al . Connective tissue disease-related interstitial lung disease (CTD-ILD) and interstitial lung abnormality (ILA): Evolving concept of CT findings, pathology and management [J]. Eur J Radiol Open , 2022 , 9 ( 7 ): 100419 - 100430 .
RAIMUNDO K , SOLOMON JJ , OLSON AL , et al . Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality [J]. J Rheumatol , 2019 , 46 ( 4 ): 360 - 369 .
KALYONCU U , BILGIN E , ERDEN A , et al . Efficacy and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data [J]. Clin Exp Rheumatol , 2022 , 40 ( 11 ): 2071 - 2077 .
CASSONE G , MANFREDI A , VACCHI C , et al . Treatment of rheumatoid arthritis-associated interstitial lung disease: lights and shadows [J]. J Clin Med , 2020 , 9 ( 4 ): 1082 - 1116 .